CASE 1-5 Flashcards
Pharmacology
(CASE 1 - SBA)
Define - Clearance (Cl)
the volume of plasma that has been cleared of drug (removed from) per unit time
Pharmacology
(CASE 1 - SBA)
Define - Half-life (t1/2
the length of time it takes for the plasma concentration of a drug to half
Pharmacology
(CASE 1 - SBA)
Define - volume of distribution (Vd)
• is the distribution of a drug between the plasma and the rest of the body after dosing Dependent on - • drug permeability across membranes • binding within compartments •pH partition
Physiology
(CASE 1 - SBA)
Define - acute inflammation
is a short-term process occurring in response to tissue injury and usually appears within mins-hours - cardinal signs - pain, redness, swelling, heat, and loss of function
Physiology
(CASE 1 - SBA)
Define - chronic inflammation
is a prolonged inflammatory response that insoles a progressive change in the type of cells present at the site of inflammation - and characterised by destruction and repair of the tissue
Pathology
(CASE 1 - SBA)
Define - atheroma
is a progressive disease characterised by the accumulation of lipids and fibrous element in the large arteries
Pathology
(CASE 1 - SBA)
Define - thrombosis
blood clot in situ in the vessels
Pathology
(CASE 1 - SBA)
Define - embolism
blood clot (or fat/air) carried around blood system which becomes lodged and causes a blockage (embolism)
Public Health
(CASE 1 - SBA)
Define - Epidemiology
is the study and analysis of the distribution, patterns and determinants of health and disease conditions in defined populations
Public Health
(CASE 1 - SBA)
Define - mortality rates
the number of deaths in a certain group of people in a certain period of time
Public Health
(CASE 1 - SBA)
Define - incidence rates
- the rate of newly diagnosed cases of a disease or illness
* the number of new cases reported in a certain period of time
Public Health
(CASE 1 - SBA)
Define - prevalence rates
is the number of individuals with the disease either at a specific point in time (the point prevalence) or over a specified time period (the period prevalence)
Pathology
(CASE 2 - SBA)
Define - ischaemia
an in adequate supply of blood to a tissue resulting in an insufficient supply of oxygen and other metabolic needs for that tissue
Pathology
(CASE 2 - SBA)
Define - infarction
an insufficient supply of blood carrying oxygen and other metabolic needs leading to cell or tissue necrosis – death
Cell Biology
(CASE 2 - SBA)
Define - Dystrophic calcification
calcification that occurs in degenerated or necrotic tissue
Cell Biology
(CASE 2 - SBA)
Define - Metastatic calcification
occurs when calcium salts are precipitated in normal tissue as a result of high serum calcium or phosphate levels
Cell Biology
(CASE 2 - SBA)
Define - necrosis
pathological cellular/tissue death in a living organism irrespective of cause and an inflammatory response
Cell Biology
(CASE 2 - SBA)
Define - apoptosis
normal or pathological individual cell death (programmed) and characterised by activation of endogenous proteases and endonucleases - NO inflammatory response
Cell Biology
(CASE 2 - SBA)
Define - pyknosis
is the irreversible condensation of chromatin in the nucleus of a cell undergoing necrosis or apoptosis
Cell Biology
(CASE 2 - SBA)
Define - free radical damage
chemical radicals characterised by a single unpaired electron in the outer shell and highly reactive
Cell Biology
(CASE 2 - SBA)
Define - hypoxia
reduced O2 delivery to the tissues
Pathology
(CASE 4 - SBA)
Define - dysplasia
- pre-cancerous - ‘typical hyperplasia’ increased cell division
- cells look abnormal
- growth is dependent on initial stimulus and the acquisition of new driver mutations
- reversible
Pathology
(CASE 4 - SBA)
Define - neoplasia
- uncontrolled cellular proliferation
- abnormal cell structure and function
- growth is independent of the initial stimulus and without the need for new mutations
- irreversible
Pathology
(CASE 4 - SBA)
Define - tumour
•
Pathology
(CASE 4 - SBA)
Define - papilloma
a benign epithelial tumour, growing in an exophytic direction (growing outwards)
Pathology
(CASE 4 - SBA)
Define - adenoma
- a benign tumour arising in glandular tissue, growing in an exophytic direction
- mucosa of stomach, small intestine and colon
Pathology
(CASE 4 - SBA)
Define - dysplasia
- pre-cancerous - ‘typical hyperplasia’ increased cell division
- cells look abnormal
- growth is dependent on initial stimulus and the acquisition of new driver mutations
- reversible
Pathology
(CASE 4 - SBA)
Define - sarcoma
a malignant tumour arising in connective or other non-epithelial tissue
• blood vessels, nerves, bones, muscles
Pathology
(CASE 4 - SBA)
Define - tumour
- an abnormal swelling
- an abnormal mass of cells resulting from the loss of normal control of cell growth and/or differentiation triggered by stepwise accumulation of multiple genetic alterations affecting a single cell and its clonal progeny
Pathology
(CASE 4 - SBA)
Define - papilloma
a benign epithelial tumour, growing in an exophytic direction (growing outwards)
Pathology
(CASE 4 - SBA)
Define - adenoma
- a benign tumour arising in glandular tissue, growing in an exophytic direction
- mucosa of stomach, small intestine and colon
Pathology
(CASE 4 - SBA)
Define - carcinoma
- a malignant tumour arising in the epithelial tissue, growing in an endophytic direction
- papilloma/adenomas can become carcinomas when they begin to grow inwards
- liver, lungs, kidney
Pathology
(CASE 4 - SBA)
Define - sarcoma
- a malignant tumour arising in connective or other non-epithelial tissue
- blood vessels, nerves, bones, muscles
Pathology
(CASE 4 - SBA)
Define - carcinoma in situ
- neoplastic cells remain growing and contained within their originating site/layer
- haven’t invaded through the basement membrane
Pathology
(CASE 4 - SBA)
Define - transformation
- the changes that normal cells undergo as they become malignant
- genetic, morphological and functional changes
Pathology
(CASE 4 - SBA)
Define - metastasis
the development of a secondary neoplastic growth in a distant tissue/organ
Pathology
(CASE 4 - SBA)
Define - invasion
the direct extension and penetration by cancer cells into neighbouring tissues by crossing their originating sites basement membrane
Pathology
(CASE 4 - SBA)
Define - grade of tumours
- histological
* appearance of the cancer cells
Pathology
(CASE 4 - SBA)
Define - stage of tumours
- anatomical
* the size of a cellular mass and how far it has spread from where it originated
Pathology
(CASE 4 - SBA)
Define - transformation
- the changes that normal cells undergo as they become malignant
- genetic, morphological and functional changes
Pathology
(CASE 4 - SBA)
Define - clonality
derived from a single cell and genetically identical
Pathology
(CASE 4 - SBA)
Define - carcinogen
- any substance, radionuclide or radiation that promotes transformation
- carcinogenesis, oncogenesis and tumorigenesis
Pathology
(CASE 4 - SBA)
Define - initiator
mutagenic and promote DNA mutations
Pathology
(CASE 4 - SBA)
Define - promoter
- non-mutagenic, act by stimulating cell division
* the original mutant population increase - increasing the likelihood of further mutations
Pathology
(CASE 4 - SBA)
Define - oncogene
- a mutated/activated gene which contributes positively to neoplasia
- usually by promoting autonomous cell proliferation
Pathology
(CASE 4 - SBA)
Define - cellular oncogene
- the unaltered (non-mutated) cellular counterpart of an oncogene
- synonymous wit proto-oncogene
Pathology
(CASE 4 - SBA)
Define - viral oncogene
- a virally encoded protein which contributes positively to neoplasm
- E6/E7 by the HPV16 virus
Pathology
(CASE 4 - SBA)
Define - tumour suppressor gene
- gene invited in regulation/ control of cell growth/cell division
- usually mutated/inactivate in cancer by -
- structural alteration
- deletion - p53
Pathology
(CASE 4 - SBA)
Define - tumour suppressor gene
- gene invited in regulation/ control of cell growth/cell division
- usually mutated/inactivate in cancer by -
- structural alteration
- deletion - p53
Public Health
(CASE 1 - SAP)
Define - health inequalities
the systematic differences in health between different groups within society – social class/ socio-economic status/deprivation or ethnicity
Social Science
(CASE 2 - SAP)
Define - patient self-care
the actions that individuals take for themselves, on behalf of and with others in order to develop, protect and maintain and improve their health, well-being and wellness (cleaning teeth, exercise, setting up and dialysis)
Public Health
(CASE 3 - SAP)
Define - absolute risk
risk of patient developing the disease over time period
Public Health
(CASE 3 - SAP)
Define - relative risk
compares 2 groups of people (smokers and non-smokers) and assesses each groups risk dependent on specific risk factors
Public Health
(CASE 3 - SAP)
Define - odds risk
measures association between and exposure and outcome
Public Health
(CASE 3 - SAP)
Define - attributable risk
is the measure of the proportion of the disease currents that can be attributed to recession exposure